MET.EXTRA GROUP SPA (MET.MI) Stock Fundamental Analysis

BIT:MET • IT0005481855

2.02 EUR
-0.02 (-0.98%)
Last: Feb 17, 2026, 07:00 PM
Fundamental Rating

4

Overall MET gets a fundamental rating of 4 out of 10. We evaluated MET against 58 industry peers in the Financial Services industry. Both the profitability and the financial health of MET get a neutral evaluation. Nothing too spectacular is happening here. MET has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year MET was profitable.
  • In the past year MET had a positive cash flow from operations.
  • MET had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: MET reported negative operating cash flow in multiple years.
MET.MI Yearly Net Income VS EBIT VS OCF VS FCFMET.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

  • With an excellent Return On Assets value of 5.90%, MET belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
  • The Return On Equity of MET (9.26%) is better than 62.07% of its industry peers.
  • The Return On Invested Capital of MET (9.82%) is better than 79.31% of its industry peers.
  • MET had an Average Return On Invested Capital over the past 3 years of 10.32%. This is in line with the industry average of 8.98%.
Industry RankSector Rank
ROA 5.9%
ROE 9.26%
ROIC 9.82%
ROA(3y)6.31%
ROA(5y)2.56%
ROE(3y)9.8%
ROE(5y)1.51%
ROIC(3y)10.32%
ROIC(5y)N/A
MET.MI Yearly ROA, ROE, ROICMET.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • MET has a Profit Margin of 5.75%. This is comparable to the rest of the industry: MET outperforms 48.28% of its industry peers.
  • Looking at the Operating Margin, with a value of 10.30%, MET is in line with its industry, outperforming 48.28% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 16.59%, MET is doing worse than 63.79% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MET has declined.
Industry RankSector Rank
OM 10.3%
PM (TTM) 5.75%
GM 16.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.46%
GM growth 5YN/A
MET.MI Yearly Profit, Operating, Gross MarginsMET.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MET is still creating some value.
  • Compared to 1 year ago, MET has about the same amount of shares outstanding.
  • MET has less shares outstanding than it did 5 years ago.
  • MET has a better debt/assets ratio than last year.
MET.MI Yearly Shares OutstandingMET.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MET.MI Yearly Total Debt VS Total AssetsMET.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of 1.57, we must say that MET is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of MET (1.57) is better than 60.34% of its industry peers.
  • MET has a debt to FCF ratio of 72.26. This is a negative value and a sign of low solvency as MET would need 72.26 years to pay back of all of its debts.
  • MET has a worse Debt to FCF ratio (72.26) than 65.52% of its industry peers.
  • A Debt/Equity ratio of 0.15 indicates that MET is not too dependend on debt financing.
  • MET has a Debt to Equity ratio of 0.15. This is in the better half of the industry: MET outperforms 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 72.26
Altman-Z 1.57
ROIC/WACC1.64
WACC6%
MET.MI Yearly LT Debt VS Equity VS FCFMET.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • MET has a Current Ratio of 1.87. This is a normal value and indicates that MET is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.87, MET is doing good in the industry, outperforming 70.69% of the companies in the same industry.
  • MET has a Quick Ratio of 1.48. This is a normal value and indicates that MET is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of MET (1.48) is better than 68.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.48
MET.MI Yearly Current Assets VS Current LiabilitesMET.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 46.44% over the past year.
  • The Revenue has grown by 30.81% in the past year. This is a very strong growth!
  • The Revenue has been growing by 126.36% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)46.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.48%
Revenue 1Y (TTM)30.81%
Revenue growth 3Y297.58%
Revenue growth 5Y126.36%
Sales Q2Q%49.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MET.MI Yearly Revenue VS EstimatesMET.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 2.89, the valuation of MET can be described as very cheap.
  • MET's Price/Earnings ratio is rather cheap when compared to the industry. MET is cheaper than 91.38% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, MET is valued rather cheaply.
Industry RankSector Rank
PE 2.89
Fwd PE N/A
MET.MI Price Earnings VS Forward Price EarningsMET.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MET indicates a rather cheap valuation: MET is cheaper than 89.66% of the companies listed in the same industry.
  • 70.69% of the companies in the same industry are more expensive than MET, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.68
EV/EBITDA 1.25
MET.MI Per share dataMET.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • MET does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MET.EXTRA GROUP SPA

BIT:MET (2/17/2026, 7:00:00 PM)

2.02

-0.02 (-0.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.17M
Revenue(TTM)50.98M
Net Income(TTM)2.93M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.89
Fwd PE N/A
P/S 0.02
P/FCF 9.68
P/OCF 0.25
P/B 0.04
P/tB 0.07
EV/EBITDA 1.25
EPS(TTM)0.7
EY34.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY10.33%
OCF(TTM)8.06
OCFY399.2%
SpS87.9
BVpS54.58
TBVpS27.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number29.32
Profitability
Industry RankSector Rank
ROA 5.9%
ROE 9.26%
ROCE 14.24%
ROIC 9.82%
ROICexc 10.31%
ROICexgc 18.81%
OM 10.3%
PM (TTM) 5.75%
GM 16.59%
FCFM 0.24%
ROA(3y)6.31%
ROA(5y)2.56%
ROE(3y)9.8%
ROE(5y)1.51%
ROIC(3y)10.32%
ROIC(5y)N/A
ROICexc(3y)10.81%
ROICexc(5y)N/A
ROICexgc(3y)24.44%
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 72.26
Debt/EBITDA 0.72
Cap/Depr 354.55%
Cap/Sales 8.94%
Interest Coverage 250
Cash Conversion 71.55%
Profit Quality 4.13%
Current Ratio 1.87
Quick Ratio 1.48
Altman-Z 1.57
F-Score6
WACC6%
ROIC/WACC1.64
Cap/Depr(3y)150.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.95%
Cap/Sales(5y)2.42%
Profit Quality(3y)203.21%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.81%
Revenue growth 3Y297.58%
Revenue growth 5Y126.36%
Sales Q2Q%49.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.94%
OCF growth 3YN/A
OCF growth 5YN/A

MET.EXTRA GROUP SPA / MET.MI FAQ

What is the fundamental rating for MET stock?

ChartMill assigns a fundamental rating of 4 / 10 to MET.MI.


What is the valuation status for MET stock?

ChartMill assigns a valuation rating of 4 / 10 to MET.EXTRA GROUP SPA (MET.MI). This can be considered as Fairly Valued.


What is the profitability of MET stock?

MET.EXTRA GROUP SPA (MET.MI) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for MET stock?

The Price/Earnings (PE) ratio for MET.EXTRA GROUP SPA (MET.MI) is 2.89 and the Price/Book (PB) ratio is 0.04.


What is the financial health of MET.EXTRA GROUP SPA (MET.MI) stock?

The financial health rating of MET.EXTRA GROUP SPA (MET.MI) is 5 / 10.